Endocrine manifestations of hepatitis C virus infection.
about
Morphologic features of extrahepatic manifestations of hepatitis C virus infectionHepatitis C virus infection and type 1 and type 2 diabetes mellitusAutoimmune and neoplastic thyroid diseases associated with hepatitis C chronic infectionTranscriptional regulation of chemokine genes: a link to pancreatic islet inflammation?Autoantibodies in chronic hepatitis C: A clinical perspectiveDouble-stranded RNA-dependent protein kinase links pathogen sensing with stress and metabolic homeostasisCommunity-based cross-sectional study: the association of lipids with hepatitis C seropositivity and diabetes mellitus.Prevalence of Diabetes Type 2 in Hepatitis C Infected Patients in Kpk, PakistanThyroid Involvement in Hepatitis C Virus-Infected Patients with/without Mixed Cryoglobulinemia.Review.Hypothyroidism in Noninterferon Treated-HCV Infected Individuals Is Associated with Abnormalities in the Regulation of Th17 Cells.Chemokine antagonism in chronic hepatitis C virus infectionHepatitis C virus syndrome: A constellation of organ- and non-organ specific autoimmune disorders, B-cell non-Hodgkin's lymphoma, and cancerHepatitis C virus induced endothelial inflammatory response depends on the functional expression of TNFα receptor subtype 2The Impact of Hepatitis B Vaccination Status on the Risk of Diabetes, Implicating Diabetes Risk Reduction by Successful VaccinationCytokines and HCV-related disorders.Thyroid dysfunction in Chinese hepatitis C patients: Prevalence and correlation with TPOAb and CXCL10Association of interferon-alpha and ribavirin-induced thyroid dysfunction with severity of disease and response to treatment in pakistani asian patients of chronic hepatitis C.Thyroid dysfunction in chinese patients with chronic hepatitis C treated with interferon alpha: incidence, long-term outcome and predictive factors.Autoimmune thyroid disorders in hepatitis C virus infection: Effect of interferon therapyImproving treatment and liver fibrosis outcomes with metformin in HCV-HIV co-infected and HCV mono-infected patients with insulin resistance: study protocol for a randomized controlled trial.Nanoparticles for transcutaneous vaccination.Thyroid hormone suppresses expression of stathmin and associated tumor growth in hepatocellular carcinomaMulti-step regulation of interferon induction by hepatitis C virus.Nutrition assessment and management in advanced liver disease.The role of chemokines in acute and chronic hepatitis C infection.The clinical significance of drug-drug interactions in the era of direct-acting anti-viral agents against chronic hepatitis C.Cytokines and HCV-related autoimmune disorders.Virus-driven autoimmunity and lymphoproliferation: the example of HCV infection.CXC chemokine IP-10: a key actor in liver disease?Current Concepts in Diabetes Mellitus and Chronic Liver Disease: Clinical Outcomes, Hepatitis C Virus Association, and Therapy.Occult endocrine dysfunction in patients with cirrhosis of liverCancer risks after solid organ transplantation and after long-term dialysis.High circulating chemokines (C-X-C motif) ligand 9, and (C-X-C motif) ligand 11, in hepatitis C-associated cryoglobulinemia.Anti-glutamic Acid decarboxylase antibody-associated ataxia as an extrahepatic autoimmune manifestation of hepatitis C infection: a case report.Thyroid autoantibodies and dysfunction do not impact the treatment efficacy of peginterferon and ribavirin combination therapy in chronic hepatitis C.Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2.Circulating CXCL11 and CXCL10 are increased in hepatitis C-associated cryoglobulinemia in the presence of autoimmune thyroiditis.Value of IL28B genotyping in patients with HCV-related mixed cryoglobulinemia: results of a large, prospective study.
P2860
Q21284981-1956315A-CE91-4477-8820-49A901CDF1D9Q26829202-C43AFCF8-433A-46D3-B206-6C0F2CE158F0Q26830844-6802FEA8-C39D-4AED-B9D9-B0FA732D09AFQ27009030-7C633121-91FE-4626-A3B6-2BD9E0FBF1D5Q28088556-84AC4FF1-7BB2-4ECD-B883-61201C7E28E6Q28510028-D3B8F6A5-0A14-40D1-82D3-E28F5B60A233Q33402027-A5BCA088-E693-477A-96D3-D82BB97161C5Q33572101-3346BDE5-86EC-4F5B-89FE-3A21458B4263Q33881738-D44B500C-9619-4253-8FA2-896A6E50EA2FQ34062040-37D2DF02-B7F3-43FF-A6CD-49A1C2D1159AQ34415214-5D4A7C87-BE04-4D53-9E3F-CDC5053F2A99Q34429056-2875107A-1CF3-43BE-BF0E-D4F0468238B1Q35237312-1E2E1BF8-AA05-462E-8453-3A07F9D6EDE6Q35445569-58D71767-A607-4565-BECF-BB9EBA741CC8Q35824137-88763FF8-3DFE-4C67-94DC-6866891C0B2AQ35960209-C3B55606-319A-4C6B-B6B4-069BB300F886Q36037935-B7A89C27-B0EF-4C4C-8F74-57DD0955DEAEQ36224788-02CFA144-92C8-4AA0-9C08-115AA1CDEBF7Q36329350-D42743B7-560A-47FB-8BC1-232E9A568987Q36862264-F748DAC3-1E89-4F83-B96D-45C636EB88B4Q37113118-2044FB80-1272-46BB-952D-1508BE270E6BQ37274692-64882B86-B65C-424E-B819-B786B273DF07Q37487309-7B32684E-1D05-4EE3-88B7-E26C973E1833Q38071909-7382DCC8-E7C8-4A33-ABB5-844CC3FAF765Q38074112-07694E71-5EB6-412E-9CF4-91BB692E456FQ38129709-D88AB0DA-3FB5-4233-94AC-DE7A682FB03FQ38152774-CADC7105-3BC9-41C6-A2C9-3A8C049381CBQ38266253-ECFF2A94-5A9D-4136-8BA8-3605298D5AEEQ38298448-A5B98252-E66E-4FAA-9102-E54255035891Q38552265-BED552B4-6701-4677-B2A2-2057F7C24290Q38606170-1610C6D5-9848-4A82-AA43-F0DE9D9B82C1Q38952317-3F02B035-479E-4B89-B640-A39421CDBF8FQ39168542-6E3F1185-7DA8-4997-9FE1-D32C9DDF92BEQ39445568-83539C67-DA0F-41B8-AE25-F9661C3E927CQ41977560-96C2AC0C-0E91-4A48-A7E2-A80758D0EB82Q43520862-45B3E31B-630D-4CE2-B5C9-08771C5F349CQ43845079-F1DE400F-5E64-4120-8116-4DB803A1F317Q44534722-7F3F0B5F-F18B-481B-A208-C28B9F9A40AFQ54268476-691F2DCA-68B3-4D10-8DB2-A34EAF627BB0
P2860
Endocrine manifestations of hepatitis C virus infection.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Endocrine manifestations of hepatitis C virus infection.
@en
Endocrine manifestations of hepatitis C virus infection.
@nl
type
label
Endocrine manifestations of hepatitis C virus infection.
@en
Endocrine manifestations of hepatitis C virus infection.
@nl
prefLabel
Endocrine manifestations of hepatitis C virus infection.
@en
Endocrine manifestations of hepatitis C virus infection.
@nl
P2093
P356
P1476
Endocrine manifestations of hepatitis C virus infection
@en
P2093
Alessandro Antonelli
Clodoveo Ferri
Poupak Fallahi
Silvia Martina Ferrari
P2860
P356
10.1038/NCPENDMET1027
P577
2009-01-01T00:00:00Z